Global Non-opioid Pain Patches Market by Patch Type (Ketoprofen, Methyl Salicylate, Diclofenac, Capsaicin, Lidocaine) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

The market for non-opioid patches in the global market was worth USD 732.6 millions in 2018. It is projected to grow at a compound annual rate (CAGR of 4.6%) between 2019 and 2026.

Many countries have turned to other options for pain management as the global opioid epidemic has grown at an alarming pace. The impact of opioid addiction on the U.S. was made a national emergency in November 2017. National Institute of Drug Abuse data shows that 90 Americans are killed each day from opioid overdose.

According to the Centers for Disease Control and Prevention, the annual economic impact of opioid misuse on the country is USD 78.5 billion. These costs include healthcare expenses, addiction treatment, lost productivity, criminal justice involvement, and healthcare spending. These numbers are a sign of how urgent it is to end addiction. This has led to an increase in demand for safer alternatives, which has boosted market growth.

Globally, pain and related disorders are growing at an alarming rate due to lifestyle changes, a lack of physical activity and a rising number of surgical procedures. According to the U.S Department of Health and Human Services, chronic and acute pain is more common than cancer, diabetes, and heart disease combined. HHS reported that pain was the leading reason patients visit healthcare facilities. This makes it the leading cause of disability and contributes to high healthcare costs. These factors encourage the development of non-opioid pain relief options, which in turn increases their market growth.

Insights from the Patch Type

The market for non-opioid pain patches is divided by type into lidocaine (diclofenac), methyl salicylate, capsaicin and ketoprofen. They are used to relieve pain and deliver drugs for a longer time. They bypass the first pass metabolism and are therefore more effective in drug delivery.

These patches are a better alternative to opioids, which can cause nausea, vomiting and respiratory depression. They also provide effective treatment for acute and chronic pain. These patches are expected to grow in demand and drive the market.

Lidocaine patches, which are non-opioid painkillers, are the most widely used for chronic and acute pain relief. Due to their proven efficacy and safety, lidocaine patches are recommended for first-line treatment of neuropathic pain in patients older than 65. This is expected to increase market growth over the forecast period.

These patches are more effective than oral diclofenac tablets and are preferred by patients because they can be applied once a day. The Flector patch, which was developed by IBSA Institut Biochimique SA, is a diclofenac-based patch that helps in the management and control of chronic and acute pain. Alpharmca Pharmaceuticals LLC, which is a subsidiary of Pfizer, Inc., licensed the product.

Because of their ease-of-use and regular use for acute pain relief, methyl salicylate patches commanded a significant market share. PanaFlex Patch, a methyl salicylate patches developed by GSK, aids in the treatment of tired and aching muscles. The product can also be used to temporarily treat arthritis and rheumatoid. Due to increased demand and adoption of alternative therapies, ketoprofen patches as well as capsaicin patches are gaining popularity in the market.

Distribution Channel Insights

The market for non-opioid pain relief patches can be divided into three categories based on their distribution channels: online pharmacies and drug stores. These products can be bought through OTC channels, depending on the doctor's recommendation. These patches can be purchased easily, but distribution channels will vary depending on the use.

Hospitals held a significant market share due to frequent patient visits/admissions in pain management. This is especially true for patients with musculoskeletal conditions and other diseases that can cause chronic and acute pain. The risk of adverse side effects from long-term painkiller use is usually higher than for short-term usage. Therefore, doctors often prescribe patches rather than oral medications.

Online pharmacies have seen a boom in the sale of medical devices and drugs. Online pharmacies make it easy to buy these products to relieve acute and chronic pain. These products can be bought online without the need for a prescription. This facilitates market growth.

Drug stores are the best place to buy prescription and OTC medicines. Because a large portion of the population is affected by pain-related disorders, prominent drug stores in the U.S. stock these products. Many people are turning to these patches to manage their pain as the country is currently facing an opioid epidemic. This has boosted the market.

Regional Insights

The largest market share was held by North America in 2018. The market is driven by the increasing incidence of pain and pain-related conditions, as well as the growing opioid epidemic in the United States. According to the American Chiropractic Association, back pain is a major problem in America. Americans spend approximately USD 50 billion annually on it. The second most common condition for which patients see doctors is back pain. It is outnumbered by upper respiratory infections. This is why it is important to develop pain relief treatments in the region. These patches are highly sought after because they relieve pain and reduce the chance of addiction.

The Asia Pacific region is experiencing a boom in the medical device and pharmaceutical industries. This region saw the fastest CAGR over the forecast period. There has been an increase in chronic and acute pain due to lifestyle-related disorders and sedentary lifestyles. Asia Pacific will see significant growth, with major developers working to make it possible to have non-opioid patches available in the region.

Latin America is also experiencing a huge burden in relation to back pain and other conditions musculoskeletal. This has led to an increase in healthcare spending. Market growth has been accelerated by a rise in patients and an increase in product knowledge & adoption.

Market Share Insights & Key Companies

This market is fragmented because many companies are involved in its development to help a large global population with chronic pain.

To increase product penetration and consumer base, market players employ a variety of technologies. The market is highly competitive with fierce competition between established players and new entrants.

Key players are also involved in mergers or acquisitions to increase their product portfolios. Acorda Therapeutics, for example, announced in July 2013 that it had acquired two products from NeurogesX Inc. to expand its portfolio of neuropathic pain management products. Qutenza, Phase 3-Stage Product NP-1998, and Phase 3 Stage Product NP-1998 were acquired for treatment of Postherpetic Neuralgia, and diabetic neuropathy.

To increase product penetration, major market players also collaborate with distributor companies. Richmar, Inc., for example, announced in October 2014 that LidoFlex pain relief patch would be distributed by two Scrip Companies companies. These companies supply chiropractic products as well as equipment and supplies for physical therapy. The market for non-opioid pain relief patches is dominated by the following players:

• Acorda Therapeutics

• Teva Pharmaceutical Industries Ltd.

• GlaxoSmithKline plc

• Endo Pharmaceuticals, Inc.

• Hisamitsu Pharmaceutical Co., Inc.

• IBSA Institut Biochimque SA

• Alkermes

• Teikoku Seiyaku Co. Ltd.

• Capsugel

• Mylan N.V.

Up Market Research published a new report titled “Non-opioid Pain Patches Market research report which is segmented by Patch Type (Ketoprofen, Methyl Salicylate, Diclofenac, Capsaicin, Lidocaine), By Players/Companies Endo Pharmaceuticals Inc, Alkermes, Capsugel, Teva Pharmaceutical Industries Ltd, Teikoku Seiyaku Co Ltd, Acorda Therapeutics, Mylan NV, Hisamitsu Pharmaceutical Co Inc, GlaxoSmithKline plc, IBSA Institut Biochimque SA”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Non-opioid Pain Patches Market Report Segments:

The market is segmented by Patch Type (Ketoprofen, Methyl Salicylate, Diclofenac, Capsaicin, Lidocaine).

Non-opioid Pain Patches Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Non-opioid Pain Patches Market

Overview of the regional outlook of the Non-opioid Pain Patches Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Non-opioid Pain Patches Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Non-opioid Pain Patches Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Ketoprofen

                2. Methyl Salicylate

                3. Diclofenac

                4. Capsaicin

                5. Lidocaine

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Non-opioid Pain Patches Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Non-opioid Pain Patches Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.